📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pharmacogenetics of Tnf Inhibitor?esponse in Rheumatoid Arthritis Utilizing the Two-Component Disease Activity Score (2020)

First Author: Gilani S

Attributed to: Maximising Therapeutic Utility for Rheumatoid Arthritis using genetic and genomic tissue responses to stratify medicines. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2217/pgs-2020-0043

PubMed Identifier: 33124499

Publication URI: http://europepmc.org/abstract/MED/33124499

Type: Journal Article/Review

Parent Publication: Pharmacogenomics

Issue: 16

ISSN: 1462-2416